Nicola Zamboni, Adjunct Professor at ETH Zurich, Institute of Molecular Systems Biology - Streamlining metabolomic and lipidomic analyses to enable personalized therapies
Step into the captivating realm of groundbreaking science performed by biomedical and omics researchers using the ZenoTOF 7600 system
“Extraordinary science" is a term created by the famous philosopher and science historian, Thomas Kuhn. It represents the excitement of making discoveries that go beyond what we currently know, challenging our understanding and paving the way for big changes in science.
At SCIEX, we are committed to empowering researchers with the latest technologies and solutions, pushing life science research to new levels.
Explore our collection of extraordinary science covering small and large molecules studies, from biomarker discovery up to translational research and beyond. Watch our engaging videos to spark your curiosity and get ready to boldly explore the unknown!
Our esteemed presenters are leaders in their respective disciplines, harnessing the power of mass spectrometry for proteomics, metabolomics and lipidomics research, to unravel the mysteries of life at a molecular level.
Each video offers a unique opportunity to explore the latest advancements and innovative approaches driving progress in biomedical and omics research.
Whether you are a seasoned scientist seeking the latest advancements or an enthusiastic learner eager to explore the intricacies of biological systems, we invite you to join our extraordinary science presenters on a journey of omics exploration and discovery.
Faster, deeper, simpler: a new era in metabolomics and lipidomics profiling
Nicola Zamboni, Adjunct Professor at ETH Zurich, Institute of Molecular Systems Biology - Streamlining metabolomic and lipidomic analyses to enable personalized therapies
Unlocking the secrets of aging-related diseases
Professor Birgit Schilling, PhD Director of the Mass Spectrometry Core Schilling Laboratory, The Buck Institute for Research on Aging - Data-independent acquisition (DIA) on a ZenoTOF 7600 system deciphered mechanisms during acute kidney injury (AKI) and differentiated 5 human breast cancer subtypes analyzing FFPE specimen
Revolutionizing the immune system study with immunopeptidomics
Professor Anthony Purcell, PhD Monash University, Biochemistry and Molecular Biology Purcell Laboratory, Monash Biomedicine - Discovery Institute Zeno SWATH DIA and the hunt for cancer antigens
Exploring high-throughput proteomics for new drug development
Hugo Gagnon Chief Scientific Officer, Allumiqs - High-throughput proteomics in drug development with Zeno SWATH DIA for PROTAC screening and CRISPR validation applications
Investigating the impactful role of proteomics in sepsis management
Iulia Macavei Jérôme Lemoine's Laboratory Institute of Analytical Sciences, France - Fast and accurate identification and antibiotic resistance profiling of microorganisms in blood cultures by SWATH DIA proteomics
Advancing personalized medicine with single cell proteomics (SCP)
Benjamin C. Orsburn, PhD Instructor of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine - Democratizing single cell proteomics with microflow time-of-flight mass spectrometry
Enhancing epigenetic modification analysis using LC-MS/MS
Ben Garcia, head of Biochemistry and Molecular Biophysics, Washington University in St. Louis - Initial impressions of the ZenoTOF 7600 system for comprehensive analysis of post-translational and post-transcriptional modifications
Proteomic profiling of drug metabolizing enzymes in the brain using LC-MS/MS
Abigail Wheeler, senior scientist at Merck - Identification of low-abundance drug metabolizing enzymes in the brain using targeted mass spectrometry-based proteomics
Lipidomics
Proteomics
Food omics
Metabolomics
Discover comprehensive solutions that facilitate both targeted and untargeted metabolomics, enabling researchers to uncover detailed metabolic profiles and gain insights into biological systems, ultimately driving discoveries in drug development, biomarker identification, and disease understanding.
Stay up-to-date with omics conversations on LinkedIn and X